W

 

FINAL DIAGNOSIS: ”“m‘%%%?9E21?3I81°35591’§'”°“5""3‘é‘da
PART 1: ADNEXUM. RIGHT, RIGHT SALP'NG°-°°P”°RE°T°MY ‘ II IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
A- OVARY W'T“ SMALL '"cwsm CYST' Ill IIIIIIIIIIIIIIIIIII IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII III

III
3' ”“REMARKABLE FALLOP'A" TUBE' I IIIIIIlIlIIllIIlIIIlIlIIIIIIIIII||IllIlIIllIIIIIIIIIIIIIIIIII

cted
Ill

PART 2: ADNEXUM, LEFT, LEFT SALPINGO-OOPHORECTOMY —
A. QVARY ngIH METASTATIC ADENOCARCINOMA.
B. UNREMARKABLE FALLOPHW TUBE. “' " w-

PART 3: UTERUS (276 GRAMS), TOTAL ABDOMINAL HYSTERECTOMY —

A. POORLY-DIFFERENTIATED ADENOCARCINOMA OF ENDOMETRIUM, PAPILLARY SEROUS TYPE, FIGO
GRADE 3. . “TOM
NEOPLASM INVADES 100% OF MYOMETRIUM POSTERIORLY WITHOUT SEROSAL EXTENSION.
NEOPLASM INVOLVES 100% OF ENDOMETRIAL SURFACE.
LYMPHOVASCULAR INVASION IDENTIFIED.
PATHOLOGIC STAGE pT3a pN1 pMX, FIGO STAGE 3C.
LEIOMYOMA, 4.5 CM.

WW???

PART 4: CERVIX, TOTAL ABDOMINAL HYSTERECTOMY —
A. PAPILLARY SEROUS ADENOCARCINOMA EXTENDING INTO ENDOCERVICAL GLANDS AND DEEPLY
INVOLVING CERVICAL STROMA.
B. NEOPLASM EXTENDS TO DEEP MARGIN OF RESECTION POSTERIORLY.
C. ECTOCERVICAL MARGIN OF RESECTION APPEARS FREE OF NEOPLASM.

PART 5: OMENTUM, OMENTECTOMY -—
UNREMARKABLE ADIPOSE TISSUE, NO NEOPLASM IDENTIFIED.

PART 6: ABDOMINAL PERITONEUM, LEFT, BIOPSY A —

UNREMARKABLE ADIPOSE TISSUE, NO NEOPLASM IDENTIFIED. /CA «ﬂ ’3
PART 7: ABDOMINAL PERITONEUM, LEFT, BIOPSY B — Q i \ Né! 91/4.“
SOFT TISSUE, NO NEOPLASM IDENTIFIED. / ’ /3
S172: WW 65%] W /
PART 8: PELVIC PERITONEUM, LEFT, BIOPSY - 5 /)//1

SOFT TISSUE, NO NEOPLASM IDENTIFIED.

PART 9: ANTERIOR CUL-DE-SAC, BIOPSY -
FIBROADIPOSE TISSUE, NO NEOPLASM IDENTIFIED.

PART 10: PELVIC PERITONEUM, RIGHT, BIOPSY-
SOFT TISSUE, NO NEOPLASM IDENTIFIED.

PART 11: ABDOMINAL PERITONEUM, RIGHT, BIOPSY A -
SOFT TISSUE, NO NEOPLASM IDENTIFIED.

PART 12: ABDOMINAL PERITONEUM, RIGHT, BIOPSY B —
SOFT TISSUE, NO NEOPLASM IDENTIFIED.

 

PART 13: LYMPH NODE, LEFT PELVIC, DISSECTION -
TWO LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/2).

PART 14: LYMPH NODES, LEFT PELVICl DISSECTION -
TWO LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/2).

PART 15: LYMPH NODES, LEFT COMMON ILIAC, DISSECTION —

TWO OF FOUR LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (2/4),

EXTENSION. ONE WITH EXTRACAPSULAR

PART 16: LYMPH NODES, LEFT PERIAORTIC, DISSECTION -
ONE OF THREE LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (1/3).

PART 17: LYMPH NODES, RIGHT PELVIC, DISSECTION -
31% ﬁglgﬁVEN LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (2”), ONE WITH EXTRACAPSULAR

PART 18: LYMPH NODES, RIGHT PELVIC, DISSECTION —
ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (1/1).

PART 19: LYMPH NODES, RIGHT PERIAORTIC, DISSECTION -
TWO OF TWO LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (2/2).

PART 20: APPENDIX, APPENDECTOMY -
_ FIBROUS OBLITERATION OF DISTAL APPENDICEAL LUMEN. NO NEOPLASM IDENTIFIED

 

CASE SYNOPSIS:
SYNOPTIC - PRIMARY UTERINE ENDOMETRIAL TUMORS: HYSTERECTOMY SPECIMENS
TUMOR TYPE: Serous adenocarcinoma
HISTOLOGIC GRADE (epithelial neoplasm) [combined architectural and nuclear]:
Poorly differentiated (FIGO 3)

ARCHITECTURAL GRADE: Poorly differentiated
NUCLEAR GRADE: Grade 3
TUMOR SIZE: Maximum dimension: 6.5 cm

PERCENT OF ENDOMETRIAL SURFACE INVOLVEMENT: -
Anterior endomyometrium: 100 %, Posterior endomyometrium: 100 °/o

DEPTH OF INVASION“: Greater than 1/2 thickness of myometrium
STRUCTURES INVOLVED: Endocervical glands, Cervical stroma, Adnexa
ANGIOLYMPHATIC INVASION: Yes
OTHER: (epithelial. smooth muscle, others). Leiomyoma
6% LYMPH NODES POSITIVE: Number of lymph nodes positive:: 8
LYMPH NODES EXAMINED: Total number of lymph nodes examined: 21

LYMPH NODE GROUPS INVOLVED: Pelvic lymph nodes, Right, Common iliac lymph nodes. Left, Para-aortic lymph nodes,
Right, Para-aortic lymph nodes, Left

EXTRANODAL EXTENSION: Yes
T STAGE, PATHOLOGIC: pTSa
N STAGE, PATHOLOGIC: pN1
M STAGE, PATHOLOGIC: pMX
FIGO STAGE: IIIC

 

